CLINICAL_TRIALS
trial_result
· 2024-02-08
Clinical Trial Update: A Clinical Study of JS005 in Patients With Ankylosing Spondylitis [Phase 2]
Summary
A Phase 2 clinical trial update for JS005 in patients with Ankylosing Spondylitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 2 | Status: UNKNOWN